126 related articles for article (PubMed ID: 26873192)
1. Artesunate as an Anti-Cancer Agent Targets Stat-3 and Favorably Suppresses Hepatocellular Carcinoma.
Ilamathi M; Santhosh S; Sivaramakrishnan V
Curr Top Med Chem; 2016; 16(22):2453-63. PubMed ID: 26873192
[TBL] [Abstract][Full Text] [Related]
2. Artesunate obliterates experimental hepatocellular carcinoma in rats through suppression of IL-6-JAK-STAT signalling.
Ilamathi M; Prabu PC; Ayyappa KA; Sivaramakrishnan V
Biomed Pharmacother; 2016 Aug; 82():72-9. PubMed ID: 27470341
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo.
Sethi G; Chatterjee S; Rajendran P; Li F; Shanmugam MK; Wong KF; Kumar AP; Senapati P; Behera AK; Hui KM; Basha J; Natesh N; Luk JM; Kundu TK
Mol Cancer; 2014 Mar; 13():66. PubMed ID: 24655440
[TBL] [Abstract][Full Text] [Related]
4. A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells.
Fu ZG; Wang L; Cui HY; Peng JL; Wang SJ; Geng JJ; Liu JD; Feng F; Song F; Li L; Zhu P; Jiang JL; Chen ZN
Oncotarget; 2016 Feb; 7(8):9429-47. PubMed ID: 26882566
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of artesunate in hepatocellular carcinoma: repurposing an ancient antimalarial agent.
Vandewynckel YP; Laukens D; Geerts A; Vanhove C; Descamps B; Colle I; Devisscher L; Bogaerts E; Paridaens A; Verhelst X; Van Steenkiste C; Libbrecht L; Lambrecht BN; Janssens S; Van Vlierberghe H
Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):861-70. PubMed ID: 24987823
[TBL] [Abstract][Full Text] [Related]
6. Enhanced delivery of artemisinin and its analogues to cancer cells by their adducts with human serum transferrin.
Yang Y; Zhang X; Wang X; Zhao X; Ren T; Wang F; Yu B
Int J Pharm; 2014 Jun; 467(1-2):113-22. PubMed ID: 24661944
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
[TBL] [Abstract][Full Text] [Related]
8. Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling.
Tan ZB; Fan HJ; Wu YT; Xie LP; Bi YM; Xu HL; Chen HM; Li J; Liu B; Zhou YC
J Ethnopharmacol; 2019 Mar; 232():62-72. PubMed ID: 30553869
[TBL] [Abstract][Full Text] [Related]
9. (-)-Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma.
Pei T; Meng Q; Han J; Sun H; Li L; Song R; Sun B; Pan S; Liang D; Liu L
Oncotarget; 2016 Jul; 7(28):43475-43491. PubMed ID: 27259268
[TBL] [Abstract][Full Text] [Related]
10. Nintedanib (BIBF-1120) inhibits hepatocellular carcinoma growth independent of angiokinase activity.
Tai WT; Shiau CW; Li YS; Chang CW; Huang JW; Hsueh TT; Yu HC; Chen KF
J Hepatol; 2014 Jul; 61(1):89-97. PubMed ID: 24657398
[TBL] [Abstract][Full Text] [Related]
11. A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.
Zhao H; Guo Y; Li S; Han R; Ying J; Zhu H; Wang Y; Yin L; Han Y; Sun L; Wang Z; Lin Q; Bi X; Jiao Y; Jia H; Zhao J; Huang Z; Li Z; Zhou J; Song W; Meng K; Cai J
Oncotarget; 2015 Oct; 6(31):31927-43. PubMed ID: 26376676
[TBL] [Abstract][Full Text] [Related]
12. XZH-5 inhibits STAT3 phosphorylation and causes apoptosis in human hepatocellular carcinoma cells.
Liu Y; Liu A; Xu Z; Yu W; Wang H; Li C; Lin J
Apoptosis; 2011 May; 16(5):502-10. PubMed ID: 21311975
[TBL] [Abstract][Full Text] [Related]
13. 17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling.
Lee S; Lee M; Kim JB; Jo A; Cho EJ; Yu SJ; Lee JH; Yoon JH; Kim YJ
Biochem Biophys Res Commun; 2016 May; 473(4):1247-1254. PubMed ID: 27091428
[TBL] [Abstract][Full Text] [Related]
14. The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib.
Hikita H; Takehara T; Shimizu S; Kodama T; Shigekawa M; Iwase K; Hosui A; Miyagi T; Tatsumi T; Ishida H; Li W; Kanto T; Hiramatsu N; Hayashi N
Hepatology; 2010 Oct; 52(4):1310-21. PubMed ID: 20799354
[TBL] [Abstract][Full Text] [Related]
15. Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma.
Subramaniam A; Shanmugam MK; Perumal E; Li F; Nachiyappan A; Dai X; Swamy SN; Ahn KS; Kumar AP; Tan BK; Hui KM; Sethi G
Biochim Biophys Acta; 2013 Jan; 1835(1):46-60. PubMed ID: 23103770
[TBL] [Abstract][Full Text] [Related]
16. LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy.
Zuo M; Li C; Lin J; Javle M
Oncotarget; 2015 May; 6(13):10940-9. PubMed ID: 25883212
[TBL] [Abstract][Full Text] [Related]
17. In vivo study of effects of artesunate nanoliposomes on human hepatocellular carcinoma xenografts in nude mice.
Jin M; Shen X; Zhao C; Qin X; Liu H; Huang L; Qiu Z; Liu Y
Drug Deliv; 2013; 20(3-4):127-33. PubMed ID: 23731485
[TBL] [Abstract][Full Text] [Related]
18. Identification of beta-escin as a novel inhibitor of signal transducer and activator of transcription 3/Janus-activated kinase 2 signaling pathway that suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells.
Tan SM; Li F; Rajendran P; Kumar AP; Hui KM; Sethi G
J Pharmacol Exp Ther; 2010 Jul; 334(1):285-93. PubMed ID: 20378717
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel Src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma.
Tai WT; Shiau CW; Chen PJ; Chu PY; Huang HP; Liu CY; Huang JW; Chen KF
Hepatology; 2014 Jan; 59(1):190-201. PubMed ID: 23908138
[TBL] [Abstract][Full Text] [Related]
20. Kurarinol induces hepatocellular carcinoma cell apoptosis through suppressing cellular signal transducer and activator of transcription 3 signaling.
Shu G; Yang J; Zhao W; Xu C; Hong Z; Mei Z; Yang X
Toxicol Appl Pharmacol; 2014 Dec; 281(2):157-65. PubMed ID: 24997323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
